Literature DB >> 28895440

Unravelling the biology of chromatin in health and cancer using proteomic approaches.

Cassandra G Eubanks1, Gerald Dayebgadoh1, Xingyu Liu1, Michael P Washburn1,2.   

Abstract

INTRODUCTION: Chromatin remodeling complexes play important roles in the control of genome regulation in both normal and diseased states, and are therefore critical components for the regulation of epigenetic states in cells. Given the role epigenetics plays in cancer, for example, chromatin remodeling complexes are routinely targeted for therapeutic intervention. Areas covered: Protein mass spectrometry and proteomics are powerful technologies used to study and understand chromatin remodeling. While impressive progress has been made in this area, there remain significant challenges in the application of proteomic technologies to the study of chromatin remodeling. As parts of large multi-subunit complexes that can be heavily modified with dynamic post-translational modifications, challenges in the study of chromatin remodeling complexes include defining the content, determining the regulation, and studying the dynamics of the complexes under different cellular states. Expert commentary: Impwortant considerations in the study of chromatin remodeling complexes include the complexity of sample preparation, the choice of proteomic methods for the analysis of samples, and data analysis challenges. Continued research in these three areas promise to yield even greater insights into the biology of chromatin remodeling and epigenetics and the dynamics of these systems in human health and cancer.

Entities:  

Keywords:  Quantitative proteomics; cancer; chromatin remodeling; epigenetics; histone modifications; mass spectrometry; protein interaction networks

Mesh:

Substances:

Year:  2017        PMID: 28895440      PMCID: PMC6118114          DOI: 10.1080/14789450.2017.1374860

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  95 in total

1.  Preparation of nuclear and cytoplasmic extracts from mammalian cells.

Authors:  Susan M Abmayr; Tingting Yao; Tari Parmely; Jerry L Workman
Journal:  Curr Protoc Mol Biol       Date:  2006-08

2.  Histone degradation in response to DNA damage enhances chromatin dynamics and recombination rates.

Authors:  Michael H Hauer; Andrew Seeber; Vijender Singh; Raphael Thierry; Ragna Sack; Assaf Amitai; Mariya Kryzhanovska; Jan Eglinger; David Holcman; Tom Owen-Hughes; Susan M Gasser
Journal:  Nat Struct Mol Biol       Date:  2017-01-09       Impact factor: 15.369

3.  A map of general and specialized chromatin readers in mouse tissues generated by label-free interaction proteomics.

Authors:  H Christian Eberl; Cornelia G Spruijt; Christian D Kelstrup; Michiel Vermeulen; Matthias Mann
Journal:  Mol Cell       Date:  2012-11-29       Impact factor: 17.970

Review 4.  Recent Achievements in Characterizing the Histone Code and Approaches to Integrating Epigenomics and Systems Biology.

Authors:  K A Janssen; S Sidoli; B A Garcia
Journal:  Methods Enzymol       Date:  2017-01-06       Impact factor: 1.600

5.  Composition and Function of Mutant Swi/Snf Complexes.

Authors:  Arnob Dutta; Mihaela Sardiu; Madelaine Gogol; Joshua Gilmore; Daoyong Zhang; Laurence Florens; Susan M Abmayr; Michael P Washburn; Jerry L Workman
Journal:  Cell Rep       Date:  2017-02-28       Impact factor: 9.423

6.  Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.

Authors:  Marcus Bantscheff; Carsten Hopf; Mikhail M Savitski; Antje Dittmann; Paola Grandi; Anne-Marie Michon; Judith Schlegl; Yann Abraham; Isabelle Becher; Giovanna Bergamini; Markus Boesche; Manja Delling; Birgit Dümpelfeld; Dirk Eberhard; Carola Huthmacher; Toby Mathieson; Daniel Poeckel; Valérie Reader; Katja Strunk; Gavain Sweetman; Ulrich Kruse; Gitte Neubauer; Nigel G Ramsden; Gerard Drewes
Journal:  Nat Biotechnol       Date:  2011-01-23       Impact factor: 54.908

7.  Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer.

Authors:  Alison M Kurimchak; Claude Shelton; Kelly E Duncan; Katherine J Johnson; Jennifer Brown; Shane O'Brien; Rashid Gabbasov; Lauren S Fink; Yuesheng Li; Nicole Lounsbury; Magid Abou-Gharbia; Wayne E Childers; Denise C Connolly; Jonathan Chernoff; Jeffrey R Peterson; James S Duncan
Journal:  Cell Rep       Date:  2016-07-21       Impact factor: 9.423

8.  Purification of proteins associated with specific genomic Loci.

Authors:  Jérôme Déjardin; Robert E Kingston
Journal:  Cell       Date:  2009-01-09       Impact factor: 41.582

9.  A travel guide to Cytoscape plugins.

Authors:  Rintaro Saito; Michael E Smoot; Keiichiro Ono; Johannes Ruscheinski; Peng-Liang Wang; Samad Lotia; Alexander R Pico; Gary D Bader; Trey Ideker
Journal:  Nat Methods       Date:  2012-11-06       Impact factor: 28.547

10.  Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs).

Authors:  Marie-Therese Mackmull; Murat Iskar; Luca Parca; Stephan Singer; Peer Bork; Alessandro Ori; Martin Beck
Journal:  Mol Cell Proteomics       Date:  2015-03-09       Impact factor: 5.911

View more
  1 in total

1.  Biomarkers of tumor invasiveness in proteomics (Review).

Authors:  Daniel L Pouliquen; Alice Boissard; Olivier Coqueret; Catherine Guette
Journal:  Int J Oncol       Date:  2020-05-28       Impact factor: 5.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.